Quantum BioPharma News - August 10, 2026
🟢 Quantum BioPharma is trading 12.75% up today after FDA cleared Lucid-MS IND for Phase 2 trial
Quantum BioPharma is trading 12.75% up now at $3.89 after the FDA cleared its Investigational New Drug application for Lucid-MS, enabling a Phase 2 trial for...
Quantum BioPharma Clears a Key FDA Hurdle for Its MS Drug — But Can a Micro-Cap Turn One Green Light Into Real Value?
Shares of Quantum BioPharma Ltd. surged as much as 7.5% to $3.71 after the company announced the FDA cleared its investigational new drug (IND) application for...
🟢 Quantum BioPharma is trading 7.54% up today after FDA approval of Lucid-MS IND
Quantum BioPharma is trading at $3.71 (+7.54%) after the FDA approved Quantum BioPharma’s IND application for Lucid-MS. - The clearance enables the company to...
🔴 Quantum BioPharma is trading 6.08% down today with no verified company-specific catalyst identified
Quantum BioPharma is trading 6.08% down at $3.24 after closing at $3.45 on August 7, 2026, with no verified company-specific announcement, earnings release, or...
🔴 Quantum BioPharma is trading 5.8% down in pre-market with no verified catalyst
Quantum BioPharma is trading 5.8% down at $3.25, after closing at $3.45 on August 7, 2026; no verified company-specific catalyst has been identified for the...